Indonesia Said Closer To Producing Own Anti-Malaria Drug
This article was originally published in PharmAsia News
Executive Summary
Indonesia's health minister says the nation is getting closer to producing a new type of artemisinin drug to fight malaria. Health Minister Siti Fadillah Supari said government researchers are growing the artemisia annual plant that produces artemisinin, until now mostly restricted to growth in China. He said the Indonesian version is showing so far to have equal or even higher artemisinin levels when compared with the variety native to China. He noted, however, that scientists have not yet been able to produce the artemisinin extract necessary for use in drugs. (Click here for more
You may also be interested in...
Incyte Hopes To Augment Immune/Inflammation Pipeline With Escient Deal
Incyte will pay $750m to acquire privately held Escient and its first-in-class oral antagonists of Mas-related G protein-coupled receptors X2 and X4.
Sanofi Clinches Key Phase III Immunology Win With Rilzabrutinib
Sanofi’s BTK inhibitor – one of two from its 2021 Principia buy – passed a Phase III test in immune thrombocytopenia as the company focuses on Dupixent-like blockbusters going forward.
US FDA Gene Therapy Accelerated Approval Guidance Will Describe ‘Buckets’ Of Use Scenarios
Forthcoming guidance is expected to describe areas of “low-hanging fruit” and those that are more challenging for use of the expedited pathway, Center for Biologics Evaluation and Research Director Peter Marks said.